136 Followers on Owler

Vericel

is a biopharmaceutical firm that develops and commercializes autologous cell therapies for the treatment of severe diseases... Read more

Overview Competitors Funding News & Insights

Vericel

is a biopharmaceutical firm that develops and commercializes autologous cell therapies for the treatment of severe diseases... Read more

President & CEO

Dominick Colangelo

CEO Approval Rating

89/100

1989

CambridgeMassachusetts

PublicNASDAQVCEL

Pharmaceuticals & Biotechnology

PharmaceuticalsBiotechnology

28342836 NAICS listing

https://www.vcel.com/

Annual Revenue

$258.7M

Employees

300

News

Conference Presentation

Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025

Vericel Competitors

1

2

3

4

5

6

7

8

9

10

Unlock 22 + competitors

Trending Companies